Bill introduced
Josh Gottheimer bought GILD
Carol D. Miller bought GILD
Jefferson Shreve bought GILD
John Boozman sold GILD
John Boozman sold GILD
Read twice and referred to the Committee on Homeland Security and Governmental Affairs.
| Registrant | Client | Amount | Filed | Period | Issues |
|---|---|---|---|---|---|
| HUMAN RIGHTS CAMPAIGN | HUMAN RIGHTS CAMPAIGN | $20.4M | Jul 16, 2025 | 2025Q2 | CIVTAXHCR |
| HUMAN RIGHTS CAMPAIGN | HUMAN RIGHTS CAMPAIGN | $19.4M | Apr 17, 2025 | 2025Q1 | HCRLAWDEF |
| THE MCMANUS GROUP |
Congress members who traded stocks in companies connected to lobbying on this bill, within 90 days of its introduction date.
| Member | Party | Ticker | Company | Trade | Date | Amount | Timing | Lobbying Client | Conflict |
|---|---|---|---|---|---|---|---|---|---|
| Josh Gottheimer | D | GILD | GILEAD SCIENCES, INC. | Buy | Mar 7, 2025 | $1,001 - $15,000 | 3d after | GILEAD SCIENCES, INC. | 31% |
| Carol D. Miller | R |
7 trades by 4 members of Congress in companies connected to lobbying on S 839. The average conflict score is 30%.
CapitolExposed identifies the "bill-lobbying-trade pipeline" by: (1) finding lobbying filings (LD-2) that specifically mention this bill, (2) matching lobbying clients to publicly traded companies, and (3) finding stock trades by members of Congress in those companies within 90 days of the bill's introduction date. Trades made before the bill was introduced are highlighted in red, as they may indicate advance knowledge. This analysis surfaces correlations worthy of scrutiny; it does not prove wrongdoing.
Lobbying filed by HUMAN RIGHTS CAMPAIGN
Lobbying filed by HUMAN RIGHTS CAMPAIGN
Lobbying filed by PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA
Lobbying filed by GILEAD SCIENCES, INC.
Lobbying filed by EMD SERONO, INC.
| PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA |
| $6.0M |
| Jul 21, 2025 |
| 2025Q2 |
MMMHCR |
| THE MCMANUS GROUP | GILEAD SCIENCES, INC. | $6.0M | Jul 21, 2025 | 2025Q2 | MMMHCR |
| THE MCMANUS GROUP | EMD SERONO, INC. | $5.0M | Jul 21, 2025 | 2025Q2 | HCRMMM |
| GILEAD SCIENCES, INC. |
| Buy |
| Mar 10, 2025 |
| $1,001 - $15,000 |
| 6d after |
| GILEAD SCIENCES, INC. |
| 38% |
| Jefferson Shreve | R | GILD | GILEAD SCIENCES, INC. | Buy | Mar 31, 2025 | $15,001 - $50,000 | 27d after | GILEAD SCIENCES, INC. | 36% |
| John Boozman | R | GILD | GILEAD SCIENCES, INC. | Sell | Apr 16, 2025 | $1,001 - $15,000 | 43d after | GILEAD SCIENCES, INC. | 18% |
| John Boozman | R | GILD | GILEAD SCIENCES, INC. | Sell | Apr 16, 2025 | $1,001 - $15,000 | 43d after | GILEAD SCIENCES, INC. | 18% |
| Jefferson Shreve | R | GILD | GILEAD SCIENCES, INC. | Sell | May 12, 2025 | $15,001 - $50,000 | 69d after | GILEAD SCIENCES, INC. | 32% |
| Josh Gottheimer | D | GILD | GILEAD SCIENCES, INC. | Sell | May 14, 2025 | $1,001 - $15,000 | 71d after | GILEAD SCIENCES, INC. | 36% |